These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26574539)

  • 1. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland.
    Bradley WG; Stommel EW; Shi X; Torbick NM; Caller TA; Sabel CE; Rooney JP; Staines A; Hardiman O
    Neurology; 2015 Nov; 85(20):1822-3. PubMed ID: 26574539
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment: the environmental and genetic impact of spatial cluster analysis in ALS.
    Veldink JH
    Neurology; 2015 Apr; 84(15):1543. PubMed ID: 25770196
    [No Abstract]   [Full Text] [Related]  

  • 3. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland.
    Rooney J; Vajda A; Heverin M; Elamin M; Crampsie A; McLaughlin R; Staines A; Hardiman O
    Neurology; 2015 Apr; 84(15):1537-44. PubMed ID: 25770197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.
    Al-Chalabi A; Calvo A; Chio A; Colville S; Ellis CM; Hardiman O; Heverin M; Howard RS; Huisman MHB; Keren N; Leigh PN; Mazzini L; Mora G; Orrell RW; Rooney J; Scott KM; Scotton WJ; Seelen M; Shaw CE; Sidle KS; Swingler R; Tsuda M; Veldink JH; Visser AE; van den Berg LH; Pearce N
    Lancet Neurol; 2014 Nov; 13(11):1108-1113. PubMed ID: 25300936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social deprivation and population density are not associated with small area risk of amyotrophic lateral sclerosis.
    Rooney JP; Tobin K; Crampsie A; Vajda A; Heverin M; McLaughlin R; Staines A; Hardiman O
    Environ Res; 2015 Oct; 142():141-7. PubMed ID: 26142719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis.
    Byrne S; Heverin M; Elamin M; Bede P; Lynch C; Kenna K; MacLaughlin R; Walsh C; Al Chalabi A; Hardiman O
    Ann Neurol; 2013 Nov; 74(5):699-708. PubMed ID: 23836460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death.
    Sabel CE; Boyle PJ; Löytönen M; Gatrell AC; Jokelainen M; Flowerdew R; Maasilta P
    Am J Epidemiol; 2003 May; 157(10):898-905. PubMed ID: 12746242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes and amyotrophic lateral sclerosis.
    Kawada T
    Eur J Neurol; 2016 Feb; 23(2):e9. PubMed ID: 26806221
    [No Abstract]   [Full Text] [Related]  

  • 9. No association between soil constituents and amyotrophic lateral sclerosis relative risk in Ireland.
    Rooney J; Vajda A; Heverin M; Crampsie A; Tobin K; McLaughlin R; Staines A; Hardiman O
    Environ Res; 2016 May; 147():102-7. PubMed ID: 26855128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: new ideas from cancer.
    Logroscino G; Ludolph A
    Lancet Neurol; 2014 Nov; 13(11):1067-1068. PubMed ID: 25300935
    [No Abstract]   [Full Text] [Related]  

  • 11. Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009.
    Caller TA; Chipman JW; Field NC; Stommel EW
    Muscle Nerve; 2013 Aug; 48(2):235-41. PubMed ID: 23881670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to the letter 'Type 2 diabetes and amyotrophic lateral sclerosis'.
    Mariosa D; Fang F
    Eur J Neurol; 2016 Apr; 23(4):e26. PubMed ID: 27000982
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyotrophic lateral sclerosis in southern Greece: an epidemiologic study.
    Kalfakis N; Vassilopoulos D; Voumvourakis C; Ndjeveleka M; Papageorgiou C
    Neuroepidemiology; 1991; 10(4):170-3. PubMed ID: 1745326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany.
    Wolf J; Wöhrle JC; Palm F; Nix WA; Maschke M; Safer A; Becher H; Grau AJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):269-74. PubMed ID: 24571628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National amyotrophic lateral sclerosis case registry.
    Varon MI
    JAMA; 1979 Jun; 241(22):2379. PubMed ID: 439312
    [No Abstract]   [Full Text] [Related]  

  • 16. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe--the French register of ALS in Limousin (FRALim register).
    Marin B; Hamidou B; Couratier P; Nicol M; Delzor A; Raymondeau M; Druet-Cabanac M; Lautrette G; Boumediene F; Preux PM;
    Eur J Neurol; 2014 Oct; 21(10):1292-300, e78-9. PubMed ID: 24909935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) #500a.
    Kasarkis EJ; Dominic K; Oddone EZ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():129-32. PubMed ID: 15512895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.
    O'Toole O; Traynor BJ; Brennan P; Sheehan C; Frost E; Corr B; Hardiman O
    J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):30-2. PubMed ID: 17634215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis and amyotrophic lateral sclerosis: finding and then losing an association.
    Albert SM
    Neuroepidemiology; 2012; 38(4):250-1. PubMed ID: 22678345
    [No Abstract]   [Full Text] [Related]  

  • 20. Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009-2011.
    Henry KA; Fagliano J; Jordan HM; Rechtman L; Kaye WE
    Am J Epidemiol; 2015 Sep; 182(6):512-9. PubMed ID: 26041711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.